4 research outputs found

    Can the intention to protect the environment lead to reduced consumption among business students?

    Get PDF
    Purpose: Modifying patterns of overconsumption towards reducing consumption as a degrowth-oriented consumer attitude is crucial to mitigating the environmental impact of high-consumption households. The aim of this article is to develop a model of the intention to reduce consumption for environmental reasons and test it among business students. Methodology/approach: Grounded in the Theory of Reasoned Action and the Theory of Planned Behaviour, the paper develops a model of consumption reduction intention. Based on a survey conducted among business students from six European Union countries, the model is tested using structural equation modelling. Findings: The study revealed the twofold influence of the intention to protect the environment on intention to reduce consumption: direct and indirect. The predictive power of the intention to protect the environment and willingness to accept the economic sacrifices in the intention to reduce consumption is confirmed as a direct effect. Additionally, the impact is mediated by a willingness to accept economic sacrifices. Originality/value: Our paper contributes to a better understanding of the intention to reduce consumption as a degrowth-oriented consumer attitude for environmental protection

    Evaluation of Nutritional Practices in the Critical Care patient (The ENPIC study) : Does nutrition really affect ICU mortality?

    No full text
    The importance of artificial nutritional therapy is underrecognized, typically being considered an adjunctive rather than a primary therapy. We aimed to evaluate the influence of nutritional therapy on mortality in critically ill patients. Methods: This multicenter prospective observational study included adult patients needing artificial nutritional therapy for >48 h if they stayed in one of 38 participating intensive care units for ≥72 h between April and July 2018. Demographic data, comorbidities, diagnoses, nutritional status and therapy (type and details for ≤14 days), and outcomes were registered in a database. Confounders such as disease severity, patient type (e.g., medical, surgical or trauma), and type and duration of nutritional therapy were also included in a multivariate analysis, and hazard ratios (HRs) and 95% confidence intervals (95%CIs) were reported. We included 639 patients among whom 448 (70.1%) and 191 (29.9%) received enteral and parenteral nutrition, respectively. Mortality was 25.6%, with non-survivors having the following characteristics: older age; more comorbidities; higher Sequential Organ Failure Assessment (SOFA) scores (6.6 ± 3.3 vs 8.4 ± 3.7; P < 0.001); greater nutritional risk (Nutrition Risk in the Critically Ill [NUTRIC] score: 3.8 ± 2.1 vs 5.2 ± 1.7; P < 0.001); more vasopressor requirements (70.4% vs 83.5%; P=0.001); and more renal replacement therapy (12.2% vs 23.2%; P=0.001). Multivariate analysis showed that older age (HR: 1.023; 95% CI: 1.008-1.038; P=0.003), higher SOFA score (HR: 1.096; 95% CI: 1.036-1.160; P=0.001), higher NUTRIC score (HR: 1.136; 95% CI: 1.025-1.259; P=0.015), requiring parenteral nutrition after starting enteral nutrition (HR: 2.368; 95% CI: 1.168-4.798; P=0.017), and a higher mean Kcal/Kg/day intake (HR: 1.057; 95% CI: 1.015-1.101; P=0.008) were associated with mortality. By contrast, a higher mean protein intake protected against mortality (HR: 0.507; 95% CI: 0.263-0.977; P=0.042). Old age, higher organ failure scores, and greater nutritional risk appear to be associated with higher mortality. Patients who need parenteral nutrition after starting enteral nutrition may represent a high-risk subgroup for mortality due to illness severity and problems receiving appropriate nutritional therapy. Mean calorie and protein delivery also appeared to influence outcomes. ClinicaTrials.gov NCT: 03634943

    Proceedings of the Frontiers of Retrovirology Conference 2016

    Get PDF
    The emergence of pandemic retroviral infection in small ruminant

    Therapeutic potential of resveratrol: the in vivo evidence

    No full text
    corecore